Pharmacy News

Hospital pharmacists say drug shortages are affecting care

New survey findings from the American Society of Health-System Pharmacists (ASHP) shows that roughly 99% of health-system pharmacists said they are experiencing drug shortages. Nearly one-third of the respondents said the current shortages are “critically impactful,” causing facilities to delay, ration, or cancel procedures or treatments.

Landmark trial finds obesity drug cuts CVD risk significantly

New findings from the SELECT trial indicate that semaglutide (Wegovy—Novo Nordisk) reduces the risk of major heart complications—heart attacks, strokes, and CV deaths—by 20%. The 5-year randomized trial of approximately 17,500 patients is the first to demonstrate that an obesity drug can have long-term CV benefits.

Few adults receive medication for opioid use disorder

A new study in JAMA Network Open found that as drug overdose deaths have reached unprecedented levels in the United States, evidence-based treatments for substance use are severely underused.

Disparities persist in Black adults’ stroke risk

According to the American Heart Association (AHA), significant disparities for stroke risk factors exist between Black adults and non-Black adults who have had a stroke.

CDC recommends new drug to protect infants from RSV

In July, FDA approved nirsevimab-alip (Beyfortus—Sanofi/AstraZeneca). A few weeks later, on August 3, 2023, CDC’s ACIP voted unanimously to recommend the broad use of the new drug to infants and high-risk children for protection against respiratory syncytial virus (RSV).